Published in Neuropsychobiology on May 12, 2005
Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases. Mol Pharmacol (2015) 1.16
Meta-analyses of 10 polymorphisms associated with the risk of schizophrenia. Biomed Rep (2014) 0.82
Genetic analysis of the human ENTH (Epsin 4) gene and schizophrenia. Schizophr Res (2006) 1.46
Association of weight gain and metabolic syndrome in patients taking clozapine: an 8-year cohort study. J Clin Psychiatry (2010) 1.45
Pharmacokinetics study for hyperprolactinemia among schizophrenics switched from risperidone to risperidone long-acting injection. J Clin Psychopharmacol (2007) 1.41
Equivalent switching dose from oral risperidone to risperidone long-acting injection: a 48-week randomized, prospective, single-blind pharmacokinetic study. J Clin Psychiatry (2007) 1.25
Neuropsychological effects after chronic subthalamic stimulation and the topography of the nucleus in Parkinson's disease. Neurosurgery (2007) 1.07
Survey of stress reactions among health care workers involved with the SARS outbreak. Psychiatr Serv (2004) 1.02
Differential regulation of neurotrophin S100B and BDNF in two rat models of depression. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.99
Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.98
Web-based tools can be used reliably to detect patients with major depressive disorder and subsyndromal depressive symptoms. BMC Psychiatry (2007) 0.97
Gene-gene interactions of the brain-derived neurotrophic-factor and neurotrophic tyrosine kinase receptor 2 genes in geriatric depression. Rejuvenation Res (2009) 0.95
Neuregulin 3 genetic variations and susceptibility to schizophrenia in a Chinese population. Biol Psychiatry (2008) 0.95
Effects of BDNF polymorphisms on brain function and behavior in health and disease. Brain Res Bull (2011) 0.94
The brain-derived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer's disease in a chinese population. Dement Geriatr Cogn Disord (2006) 0.94
Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders. Eur Neuropsychopharmacol (2006) 0.94
Association of initial antipsychotic response to clozapine and long-term weight gain. Am J Psychiatry (2006) 0.91
Antidepressant mechanism of add-on repetitive transcranial magnetic stimulation in medication-resistant depression using cerebral glucose metabolism. J Affect Disord (2010) 0.91
Association study of a functional catechol-O-methyltransferase genetic polymorphism with age of onset, cognitive function, symptomatology and prognosis in chronic schizophrenia. Neuropsychobiology (2004) 0.89
Effects of BDNF polymorphisms on antidepressant action. Psychiatry Investig (2010) 0.89
Association study of oestrogen receptor alpha gene polymorphism and suicidal behaviours in major depressive disorder. Psychiatr Genet (2003) 0.88
Association study of brain-derived neurotrophic factor and apolipoprotein E polymorphisms and cognitive function in aged males without dementia. Neurosci Lett (2008) 0.87
Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients. Neuromolecular Med (2004) 0.86
Weight gain with clozapine: 8-year cohort naturalistic study among hospitalized Chinese schizophrenia patients. Schizophr Res (2009) 0.86
Reliability of information provided by patients of a virtual psychiatric clinic. Psychiatr Serv (2003) 0.85
The evaluation of Game-Based e-learning for medical education: a preliminary survey. AMIA Annu Symp Proc (2005) 0.85
Support for the involvement of the ERBB4 gene in schizophrenia: a genetic association analysis. Neurosci Lett (2010) 0.85
Plasminogen activator inhibitor-1 gene is associated with major depression and antidepressant treatment response. Pharmacogenet Genomics (2008) 0.84
Artificial neural network prediction of clozapine response with combined pharmacogenetic and clinical data. Comput Methods Programs Biomed (2008) 0.84
Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment. Pharmacogenet Genomics (2010) 0.84
Easy and low-cost identification of metabolic syndrome in patients treated with second-generation antipsychotics: artificial neural network and logistic regression models. J Clin Psychiatry (2009) 0.84
ENU mutagenesis identifies mice with morbid obesity and severe hyperinsulinemia caused by a novel mutation in leptin. PLoS One (2010) 0.84
Association study of a functional catechol-O-methyltransferase polymorphism and executive function in elderly males without dementia. Neurosci Lett (2008) 0.84
Heterozygote advantage of the MTHFR C677T polymorphism on specific cognitive performance in elderly Chinese males without dementia. Dement Geriatr Cogn Disord (2011) 0.83
C825T polymorphism in the human G protein beta3 subunit gene is associated with long-term clozapine treatment-induced body weight change in the Chinese population. Pharmacogenet Genomics (2005) 0.83
Support for association of the A277C single nucleotide polymorphism in human vesicular monoamine transporter 1 gene with schizophrenia. Schizophr Res (2007) 0.83
Analysis of genetic variations in the RGS9 gene and antipsychotic-induced tardive dyskinesia in schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2009) 0.83
Association study of adrenergic beta3 receptor (Trp64Arg) and G-protein beta3 subunit gene (C825T) polymorphisms and weight change during clozapine treatment. Neuropsychobiology (2004) 0.83
Brain-derived neurotrophic factor and antidepressant action: another piece of evidence from pharmacogenetics. Pharmacogenomics (2008) 0.83
Improved body weight and metabolic outcomes in overweight or obese psychiatric patients switched to amisulpride from other atypical antipsychotics. J Clin Psychopharmacol (2009) 0.82
The association of RAB18 gene polymorphism (rs3765133) with cerebellar volume in healthy adults. Cerebellum (2014) 0.82
Manic symptoms induced by paliperidone. J Clin Psychopharmacol (2010) 0.82
Association analysis for neuronal nitric oxide synthase gene polymorphism with major depression and fluoxetine response. Neuropsychobiology (2003) 0.82
Association analysis of polymorphisms in the N-methyl-D-aspartate (NMDA) receptor subunit 2B (GRIN2B) gene and tardive dyskinesia in schizophrenia. Psychiatry Res (2007) 0.82
Association study of the estrogen receptor polymorphisms with tardive dyskinesia in schizophrenia. Neuropsychobiology (2002) 0.82
Allelic variants of the tryptophan hydroxylase (A218C) and serotonin 1B receptor (A-161T) and personality traits. Neuropsychobiology (2003) 0.82
Family-based association study between G72/G30 genetic polymorphism and schizophrenia. Neuroreport (2006) 0.82
Aripiprazole-associated acute dystonia, akathisia, and parkinsonism in a patient with bipolar I disorder. J Clin Psychopharmacol (2013) 0.81
Association of missense variants of the PRKC, apoptosis, WT1, regulator (PAWR) gene with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.81
Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and tardive dyskinesia in patients with schizophrenia. Pharmacogenet Genomics (2006) 0.81
Recent molecular genetic studies and methodological issues in suicide research. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.81
Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study. Schizophr Res (2009) 0.81
Satisfaction with eGroups among persons with psychiatric disorders. Psychiatr Serv (2004) 0.81
Association study of HLA-A gene and schizophrenia in Han Chinese from Taiwan. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.81
Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder. Psychiatry Res (2009) 0.81
The human dopamine receptor D2 (DRD2) gene is associated with tardive dyskinesia in patients with schizophrenia. Schizophr Res (2006) 0.80
Effect of Bcl-2 rs956572 SNP on regional gray matter volumes and cognitive function in elderly males without dementia. Age (Dordr) (2011) 0.80
Association study of p11 gene with major depressive disorder, suicidal behaviors and treatment response. Neurosci Lett (2008) 0.80
Exomic sequencing of the ionotropic glutamate receptor N-methyl-D-aspartate 3A gene (GRIN3A) reveals no association with schizophrenia. Schizophr Res (2009) 0.80
Interleukin-1 beta (C-511T) genetic polymorphism is associated with cognitive performance in elderly males without dementia. Neurobiol Aging (2008) 0.80
No association for D2 and D4 dopamine receptor polymorphisms and methamphetamine abuse in Chinese males. Psychiatr Genet (2002) 0.80
Stem cell-based neuroprotective and neurorestorative strategies. Int J Mol Sci (2010) 0.79
Sexually dimorphic effect of catechol-O-methyltransferase val158met polymorphism on clinical response to fluoxetine in major depressive patients. J Affect Disord (2008) 0.79
Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics. Schizophr Res (2010) 0.79
Association study of brain-derived neurotrophic factor gene polymorphisms and body weight change in schizophrenic patients under long-term atypical antipsychotic treatment. Neuromolecular Med (2011) 0.79
Interleukin-1 beta -511C/T genetic polymorphism is associated with age of onset of geriatric depression. Neuromolecular Med (2009) 0.79
Evidence for association between genetic variants of p75 neurotrophin receptor (p75NTR) gene and antidepressant treatment response in Chinese major depressive disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 0.79
Association of MTHFR C677T polymorphism with loneliness but not depression in cognitively normal elderly males. Neurosci Lett (2012) 0.79
Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia. J Clin Psychiatry (2007) 0.78
Resequencing and association study of vesicular glutamate transporter 1 gene (VGLUT1) with schizophrenia. Schizophr Res (2009) 0.78
Norepinephrine transporter and alpha(2c) adrenoceptor allelic variants and personality factors. Am J Med Genet (2002) 0.78